Companies / Creative Biolabs / Anti-FMC63 scFv Monoclonal Antibody, FITC-Conjugated
Creative Biolabs

Anti-FMC63 scFv Monoclonal Antibody, FITC-Conjugated | Creative Biolabs

(0) Write Review

FMC63 is a CD19-specific IgG1 mouse monoclonal antibody, which is a target for immunotherapy of B-lineage leukemia and lymphoma. FMC63 scFv is the most commonly used extracellular domain component of CD19-specific CARs. So far, most of the reported CART-CD19 clinical trials contain anti-CD19 scFv derived from FMC63, such as the two FDA-approved CARs Kymriah and Yescarta. This product was verified to specifically recognize the antigen recognition domain of FMC63-derived CAR.

Request Quote

Supporting Documents

Data Sheet

Datasheet

Reviews

(0) | Be the first to review this product
No reviews yet
Scientific Products
  • See More
    • Upcoming Virtual Events
    Upcoming Webinars